Abstract
Introduction : Acinetobacter bereziniae IJ5 is a Gram-negative bacterium notorious for multidrug resistance and poses a significant risk for nosocomial infections. This study focuses on the genomic characterization of A. bereziniae strain IJ5, recovered from drinking water in Dhaka, Bangladesh. Through comparative genome analysis with other global strains, we determine its pathogenicity, virulence, and adaptation strategies.
Methods: The genome of A. bereziniae was sequenced using Illumina MiniSeq, followed by assembly with Shovill on Galaxy and annotation through RAST and PGAP in NCBI. The bioinformatics analyses carried out revealed antibiotic resistance genes, virulome, toxin–antitoxin systems, secondary metabolites, and prophage sequences, with the goal of identifying the factors that contribute to its pathogenicity.
Result : A unique combination of MDR genes such as qacG, adeF, OXA-355, and vanG was identified, coupled with diverse toxin–antitoxin systems consisting of RelE/RelB, ParE/ParD, and HigB/HigA, underscoring the high survival capability of IJ5. The genome of A.bereziniae IJ5 has a GC content of 38% and a total size of 4.4 Mb. The presence of distinct metabolic pathways, such as Ni-siderophores, RiPP-like compounds, and arylpolyenes, contributes to the resilience of IJ5 in clinical environments. IJ5’s pathogenicity score of 77.2% indicates a strong potential to infect humans, enhanced by regulatory
elements. IJ5 is closely related to the AB839 (Taiwan) and FFMG-36-12-21 (Tanzania) strains of A. bereziniae, as they share a common ancestor; additionally no other strains cluster with IJ5, portraying its unique sub-lineage.
Conclusion: The genomic analysis of A. bereziniae reveals a distinctive mixture of MDR genes and toxin–antitoxin systems, showing an enhanced adaptability in clinical settings. A high pathogenicity score of 77.2% indicates strong infection potential, likely reinforced by regulatory elements. Comparative analysis further shows the genomic plasticity and persistence of IJ5, highlighting the necessity for continuous surveillance and research to develop targeted infection control and treatment strategies within Bangladeshi healthcare facilities.
